Cipla has received approval to distribute and market inhaled insulin in India. This innovative treatment offers a needle-free option for diabetes patients.
With no need for injections, it provides greater convenience and comfort for users. This is a big step toward making diabetes management easier for people across the country.
This milestone marks the beginning of a new era in healthcare, bringing advanced treatment options closer to those who need them most.
